UPA and MMP-2 were involved in self-assembled network formation in a two dimensional co-culture model of bone marrow stromal cells and endothelial cells

Journal of Cellular Biochemistry

Volumn 114, Issue 3, 2013, Pages 650-657

  Li, Haiyan ^a,b   Daculsi, Richard ^a   Bareille, Reine ^a   Bourget, Chantal ^a   Amedee, Joëlle ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

ANGIOGENESIS; CO CULTURE; ENDOTHELIAL CELLS; MMP 2; uPA

Indexed keywords

GELATINASE A; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UROKINASE;

ARTICLE; BONE MARROW CELL; BONE MARROW STROMAL CELL; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONOCULTURE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; STROMA CELL; UMBILICAL VEIN ENDOTHELIAL CELL;

BONE MARROW CELLS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MOVEMENT; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE INHIBITORS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOLYSIS; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UP-REGULATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84872795102     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24407     Document Type: Article

References (40)

1. Arnold F, West DC,. 1991. Angiogenesis in wound healing. Pharmacol Ther 52: 407-422.
2. Berton A, Rigot V, Huet E, Decarme M, Eeckhout Y, Patthy L, Godeau G, Hornebeck W, Bellon G, Emonard H,. 2001. Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids. J Biol Chem 276: 20458-20465.
3. Bini A, Wu D, Schnuer J, Kudryk BJ,. 1999. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments. Biochemistry 38: 13928-13936.
4. Bischoff J,. 1995. Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol 5: 69-74.
5. Bishop ET, Bell GT, Bloor S, Broom IJ, Hendry NF, Wheatley DN,. 1999. An in vitro model of angiogenesis: Basic features. Angiogenesis 3: 335-344.
6. Cao J, Sato H, Takino T, Seiki M,. 1995. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 270: 801-805.
7. Carmeliet P,. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395.
8. Carmeliet P, Collen D,. 1998. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res 91: 255-285.
9. Cockerill GW, Gamble JR, Vadas MA,. 1995. Angiogenesis: Models and modulators. Int Rev Cytol 159: 113-160.
10. Collen A, Hanemaaijer R, Lupu F, Quax PH, van Lent N, Grimbergen J, Peters E, Koolwijk P, van Hinsbergh VW,. 2003. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood 101: 1810-1817.
11. Corcoran ML, Emmert-Buck MR, McClanahan JL, Pelina-Parker M, Stetler-Stevenson WG,. 1996. TIMP-2 mediates cell surface binding of MMP-2. Adv Exp Med Biol 389: 295-304.
12. Cornelius LA, Nehring LC, Roby JD, Parks WC, Welgus HG,. 1995. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J Invest Dermatol 105: 170-176.
13. Dennis PA, Rifkin DB,. 1990. Studies on the role of basic fibroblast growth factor in vivo: Inability of neutralizing antibodies to block tumor growth. J Cell Physiol 144: 84-98.
14. Finkenzeller G, Arabatzis G, Geyer M, Wenger A, Bannasch H, Stark GB,. 2006. Gene expression profiling reveals platelet-derived growth factor receptor alpha as a target of cell contact-dependent gene regulation in an endothelial cell-osteoblast co-culture model. Tissue Eng 12: 2889-2903.
15. Folkman J,. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31.
16. Fuchs S, Hofmann A, Kirkpatrick CJ,. 2007. Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng 13: 2577-2588.
17. Garcia-Touchard A, Henry TD, Sangiorgi G, Spagnoli LG, Mauriello A, Conover C, Schwartz RS,. 2005. Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol 25: 1119-1127.
18. Grellier M, Ferreira-Tojais N, Bourget C, Bareille R, Guillemot F, Amedee J,. 2009. Role of vascular endothelial growth factor in the communication between human osteoprogenitors and endothelial cells. J Cell Biochem 106: 390-398.
19. Haas TL, Madri JA,. 1999. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: Implications for angiogenesis. Trends Cardiovasc Med 9: 70-77.
20. Koike T, Vernon RB, Hamner MA, Sadoun E, Reed MJ,. 2002. MT1-MMP, but not secreted MMPs, influences the migration of human microvascular endothelial cells in 3-dimensional collagen gels. J Cell Biochem 86: 748-758.
21. Lamalice L, Le Boeuf F, Huot J,. 2007. Endothelial cell migration during angiogenesis. Circ Res 100: 782-794.
22. Lewalle JM, Munaut C, Pichot B, Cataldo D, Baramova E, Foidart JM,. 1995. Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J Cell Physiol 165: 475-483.
23. Li H, Daculsi R, Grellier M, Bareille R, Bourget C, Amedee J,. Role of neural-cadherin in early osteoblastic differentiation of human bone marrow stromal cells cocultured with human umbilical vein endothelial cells. Am J Physiol Cell Physiol 299: C422-C430.
24. Li H, Daculsi R, Grellier M, Bareille R, Bourget C, Remy M, Amedee J,. The role of vascular actors in two dimensional dialogue of human bone marrow stromal cell and endothelial cell for inducing self-assembled network. PLoS One 6: e16767.
25. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S,. 1981. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41: 4629-4636.
26. Mignatti P, Rifkin DB,. 1996. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49: 117-137.
27. Montesano R, Pepper MS, Orci L,. 1993. Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts. J Cell Sci 105: 1013-1024.
28. Nehls V, Drenckhahn D,. 1995. A microcarrier-based cocultivation system for the investigation of factors and cells involved in angiogenesis in three-dimensional fibrin matrices in vitro. Histochem Cell Biol 104: 459-466.
29. Pei D, Weiss SJ,. 1996. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271: 9135-9140.
30. Pepper MS,. 2001. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21: 1104-1117.
31. Prager GW, Breuss JM, Steurer S, Mihaly J, Binder BR,. 2004. Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells. Blood 103: 955-962.
32. Santos MI, Unger RE, Sousa RA, Reis RL, Kirkpatrick CJ,. 2009. Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone- starch scaffold and the in vitro development of vascularization. Biomaterials 30: 4407-4415.
33. Sato H, Okada Y, Seiki M,. 1997. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion. Thromb Haemost 78: 497-500.
34. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M,. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
35. Snoek-van Beurden PA, Von den Hoff JW,. 2005. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Biotechniques 38: 73-83.
36. Sorrell JM, Baber MA, Caplan AI,. 2007. A self-assembled fibroblast-endothelial cell co-culture system that supports in vitro vasculogenesis by both human umbilical vein endothelial cells and human dermal microvascular endothelial cells. Cells Tissues Organs 186: 157-168.
37. Ugwu F, Van Hoef B, Bini A, Collen D, Lijnen HR,. 1998. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3). Biochemistry 37: 7231-7236.
38. Villars F, Guillotin B, Amedee T, Dutoya S, Bordenave L, Bareille R, Amedee J,. 2002. Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 282: C775-C785.
39. Yu H, VandeVord PJ, Mao L, Matthew HW, Wooley PH, Yang SY,. 2009. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. Biomaterials 30: 508-517.
40. Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ, Cao J,. 1998. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273: 1216-1222.